# FDA 483 - Uptown Research Institute - April 13, 2018

Source: https://www.globalkeysolutions.net/records/483/uptown-research-institute/6568bf89-9382-42a7-9da2-e8705269f52c

> FDA 483 for Uptown Research Institute on April 13, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Uptown Research Institute
- Inspection Date: 2018-04-13
- Product Type: drugs
- Office Name: Chicago District Office
- Summary: Uptown Research Institute, a biopharmaceutical clinical facility in Chicago, IL, was inspected by the FDA. The inspection revealed a significant issue regarding the retention of reserve samples for investigational products. Specifically, the facility failed to retain reserve samples from multiple shipments of investigational product during a specific protocol.

## Related Officers

- [Debra L. Boyd-Seale](https://www.globalkeysolutions.net/people/debra-l-boyd-seale/6f9af6f9-8deb-494d-b73e-fca63b95d7d2)
- [issuing_officer](https://www.globalkeysolutions.net/people/susan-d-yuscius/2facd4c5-591b-4391-a361-271f959fb52a)

Company: https://www.globalkeysolutions.net/companies/uptown-research-institute/f404e2b3-3f58-4d1a-9a8c-805059275fed

Office: https://www.globalkeysolutions.net/offices/chicago-district-office/a510300b-0eaf-4a33-90b5-231d95977669
